Female sexual dysfunction: Is pharmacologic treatment a future reality or just wishful thinking?

Article Type
Changed
Tue, 08/28/2018 - 11:04
Display Headline
Female sexual dysfunction: Is pharmacologic treatment a future reality or just wishful thinking?

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Author and Disclosure Information

Jan Shifren, MD, is President, North American Menopause Society (NAMS) and Director, Midlife Women's Health Center, Boston, Massachusetts

Issue
OBG Management - 26(10)
Publications
Topics
Legacy Keywords
Jan Shifren MD, female sexual dysfunction, treatment, testosterone, flibanserin, NAMS, North American Menopause Society
Sections
Author and Disclosure Information

Jan Shifren, MD, is President, North American Menopause Society (NAMS) and Director, Midlife Women's Health Center, Boston, Massachusetts

Author and Disclosure Information

Jan Shifren, MD, is President, North American Menopause Society (NAMS) and Director, Midlife Women's Health Center, Boston, Massachusetts

Related Articles

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Issue
OBG Management - 26(10)
Issue
OBG Management - 26(10)
Publications
Publications
Topics
Article Type
Display Headline
Female sexual dysfunction: Is pharmacologic treatment a future reality or just wishful thinking?
Display Headline
Female sexual dysfunction: Is pharmacologic treatment a future reality or just wishful thinking?
Legacy Keywords
Jan Shifren MD, female sexual dysfunction, treatment, testosterone, flibanserin, NAMS, North American Menopause Society
Legacy Keywords
Jan Shifren MD, female sexual dysfunction, treatment, testosterone, flibanserin, NAMS, North American Menopause Society
Sections
Disallow All Ads